Net Net Stock Overview

Subscribe

To see hundreds more international net nets, consider subscribing

Overview

Neurometrix Inc
Healthcare
P/NCAV
0.24x
Ticker
NURO
Exchange
NASDAQ
Country
United States
Close
4.44 $
Mkt Cap
4.6M $
EV
2.9M $
NCAV Burn Rate
14.4%
Current Ratio
16.8
Debt/Equity
0.0
EV/REV
0.49x
EV/EBIT
-0.4x
EV/FCF
-0.5x
Dilution
93.6% p.A
Total Net Income
-63.8M $
Cheapness
99.0%
NeuroMetrix, Inc. is a commercial-stage healthcare company that develops and commercializes neurotechnology devices to address unmet needs in the chronic pain and diabetes markets. The Company-s products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The Company has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. It operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.

Profitability

positive values --- Average negative values

Margins

--- Average

Valuation

positive values --- Average negative values

Dilution

--- Average